INFUSE helps improve vaccine delivery systems by connecting high-impact innovations with the countries that need them most
Vaccine delivery systems in developing countries often rely on technologies and approaches that haven't been updated in years or sometimes decades. This can slow or even stop the delivery of life-saving vaccines.
There are many potential solutions but they lack the right market conditions for scale-up. Businesses offering new technology frequently struggle to secure the necessary funding, while governments can lack the expertise required to select appropriate, cost-effective solutions.
INFUSE aims to address this challenge by connecting tried and tested innovations to the countries that need them most.
HOW INFUSE WORKS
- Call for innovations: each year, a panel of reviewers selects innovative technology and approaches, which have the potential to improve vaccine delivery.
- The INFUSE community: selected businesses and innovators join the INFUSE community to collaborate on ways to improve, align and integrate their innovations.
- Workshop: the INFUSE community convenes for an annual workshop where participants pitch their innovations to a review panel.
- Pacesetters: the panel selects the most promising proposals as INFUSE Pacesetters. Selected businesses and innovators are connected to Vaccine Alliance partners able to help take their solutions to scale.
From ideas to impact: how INFUSE works
INFUSE review panel 2016
Ashoka, US Center for Disease Control and Prevention (CDC), FSG, IBM, International Telecommunication Union (ITU), Mezzanine, PATH, Philips, UNICEF Innovation, United Parcel Service (UPS), Vodafone, World Economic Forum (WEF), World Health Organization (WHO), Zipline.
PDF: About Gavi INFUSE